Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated dose study of NPC-25 in healthy adult male volunteers
jRCT2031210090Phase 1Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zinc histidine hydrate in zinc deficiency (6 arms), sponsored by Nobelpharma Co., Ltd. Started Mar 2021; status: completed.
02
Drugs
zinc histidine hydrate
03
Conditions
zinc deficiency
Beyond the preview
Go deeper on jRCT2031210090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210090.